Increased urotensin-II activity in patients with Raynaud's phenomenon and systemic lupus erythematosus


Buyukhatipoglu H., Buyukaslan H., Pehlivan Y., Ceylan N., Ulas T., Tarakcioglu M., ...More

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, vol.14, no.3, pp.276-281, 2011 (Peer-Reviewed Journal) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 14 Issue: 3
  • Publication Date: 2011
  • Doi Number: 10.1111/j.1756-185x.2011.01597.x
  • Journal Name: INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES
  • Journal Indexes: Science Citation Index Expanded, Scopus
  • Page Numbers: pp.276-281

Abstract

Aim: Raynaud's phenomenon (RP) commonly co-exists with systemic lupus erythematosus (SLE). The obvious pathophysiological mechanism in RP is vasoconstriction. Although the roles of certain vasoconstrictor substances, like endothelin-1, have been identified in RP, underlying mechanisms remain unclear.